Click on a filter below to refine your search. Remove a filter to broaden your search.
An increase was seen in prebronchodilator forced expiratory volume in one second with dupilumab versus placebo at weeks 12 and 52.
No reduction was seen in the number of self-reported exacerbations treated with oral corticosteroids, antibiotics or both.